GlassScriptPhysician profile
Alexander Shapsis
NPI 1952325599
$75,947.40
in general payments reported to CMS, 2019-2025
45 companies · $9,283 in 2025
The $9,283 reported for 2025 was more than what 92% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $7,043 · 2021: $14K · 2022: $13K · 2023: $5,587 · 2024: $5,455 · 2025: $9,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $7,687 · Travel and Lodging: $1,306 · Education: $83.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,250.00 |
| Food and Beverage | $7,686.51 |
| Travel and Lodging | $1,305.72 |
| Education | $83.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $35,423.60 | 2019-2025 | Creon, Linzess, Viberzi |
| Gilead Sciences, INC. | $27,975.87 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,890.40 | 2019-2025 | Xifaxan, Trulance |
| Apollo Endosurgery US INC | $1,587.64 | 2023 | Overstitch Endoscopic Suturing System |
| Romark Laboratories, Lc | $1,132.05 | 2019 | |
| Janssen Biotech, INC. | $811.34 | 2019-2025 | Tremfya, Stelara |
| Qol Medical, LLC | $762.60 | 2019-2024 | Sucraid, Sucraid |
| Celgene Corporation | $758.40 | 2021-2024 | Zeposia |
| Ardelyx, INC. | $610.09 | 2023-2025 | Ibsrela |
| Pfizer INC. | $558.01 | 2019-2025 | |
| Madrigal Pharmaceuticals | $435.46 | 2024-2025 | Rezdiffra, Resmetirom |
| Phathom Pharmaceuticals, INC. | $392.80 | 2024-2025 | Voquezna |
| Vivus LLC | $362.65 | 2021-2025 | Pancreaze |
| Ironwood Pharmaceuticals, INC | $349.57 | 2019-2024 | Linzess |
| Intercept Pharmaceuticals, INC. | $279.30 | 2019-2023 | Ocaliva |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $272.04 | 2021-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Nestle Healthcare Nutrition INC. | $226.48 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $219.80 | 2019-2025 | Entyvio |
| Daiichi Sankyo INC. | $202.11 | 2020-2022 | |
| Lilly USA, LLC | $194.82 | 2024-2025 | Omvoh, Zepbound |
| Redhill Biopharma INC. | $192.46 | 2020-2024 | Talicia |
| Aimmune Therapeutics, INC. | $159.79 | 2024-2025 | Zenpep, Vowst |
| Braintree Laboratories, INC. | $147.30 | 2021-2025 | Sutab, Suflave |
| Endo Pharmaceuticals INC. | $101.49 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $94.86 | 2019-2024 | Dificid, Lagevrio |
| Celltrion USA INC. | $72.83 | 2024-2025 | Vegzelma |
| Ucb, INC. | $72.17 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $67.83 | 2019-2020 | |
| Novo Nordisk INC | $67.40 | 2025 | Wegovy |
| Ipsen Biopharmaceuticals, INC | $66.24 | 2024-2025 | Iqirvo |
| Shionogi INC | $58.18 | 2019 | |
| Capsovision, INC. | $56.21 | 2023-2024 | Capsocam Plus |
| Currax Pharmaceuticals LLC | $47.28 | 2023-2024 | Contrave, Onzetra Xsail |
| Astrazeneca Pharmaceuticals LP | $39.03 | 2025 | |
| Alexion Pharmaceuticals, INC. | $33.60 | 2019 | |
| Orphalan INC | $33.59 | 2024 | Cuvrior |
| Evoke Pharma, INC. | $30.45 | 2023-2024 | Gimoti |
| Boston Scientific Corporation | $26.12 | 2025 | Overstitch Endoscopic Suturing System |
| Shire North American Group INC | $23.34 | 2019 | |
| Olympus America INC. | $23.17 | 2023 | Single Use Electrosurgical Snare Sd-400 |
| E.R. Squibb & Sons, L.L.C. | $22.11 | 2021 | |
| Alnylam Pharmaceuticals INC. | $19.57 | 2021 | |
| Micro-Tech Endoscopy USA, INC. | $17.91 | 2024 | Lockado |
| Oxford Immunotec USA INC | $17.46 | 2022 | |
| Allergan, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Shapsis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.